ca management ms 2006
TRANSCRIPT
-
8/10/2019 CA Management Ms 2006
1/53
Overview of ACLS
May 2006
-
8/10/2019 CA Management Ms 2006
2/53
900,000 people in the U.S. experience anMI annually
~225,000 die
~125,000 die in the field
Most deaths are arrhythmic in etiology
Acute Myocardial Infarction
Data from: Ryan TJ et al. J Am Coll Cardiol . 1996;28:1333.
-
8/10/2019 CA Management Ms 2006
3/53
Mechanisms of CA
80-90% of non-traumatic cardiac arrests inadults are due to VF or PVTThe key action is early defibrillationMost arrests in children are respiratoryThe key action is ventilation
-
8/10/2019 CA Management Ms 2006
4/53
Success of Defibrillation is
Time-Dependent
0
1020
30
40
50
60
70
80
90
1 2 3 4 5 6 7 8 9
SUCCESS
Minutes to
Defibrillation
Success is reduced 7-10% per minute
-
8/10/2019 CA Management Ms 2006
5/53
AED
The AED assesses therhythm and advisesshocks for VT/VF
After shocks resumeCPR and reassessrhythm after 5 cycles(two) minutesIf pulse returns, assessand assist breathing
-
8/10/2019 CA Management Ms 2006
6/53
Pulseless VT/VFWitnessed: Consider precordial thump(optional, may be harmful)Unwitnessed: CPR for 2 minutes prior toshockShock 1 time. Level of energy withmonophasic shock: 360 J. Biphasic:
120-200J.Resume CPR immediately after shock.Check rhythm after 2 minutes
-
8/10/2019 CA Management Ms 2006
7/53
Pulseless VT/VF Persists
After Shock Start DrugsThe key drug in CA mgmt is epinephrineFor every type of CA, epinephrine is
given every 3-5 minutes until a pulse isrestoredVasopressin ( 40 u) may be giveninstead of the first or second dose ofepinephrineSimultaneously, intubate, oxygenateventilate
-
8/10/2019 CA Management Ms 2006
8/53
CPR Pointers
The compresssion rate is 100 per minute.Be sure compressions are full (1 - 2) andfast , but be sure that chest recoil iscomplete between compressions.Hand position is mid-sternal at nipple line
-
8/10/2019 CA Management Ms 2006
9/53
CPR Pointers
Minimize all CPR interruptionsOnce the patient is intubated do notinterrupt chest compressions forventilationFollowing intubation: Ventilation rate is 8-10 per minute. Do not hyperventilate
-
8/10/2019 CA Management Ms 2006
10/53
Pulseless VT/VF
Proceed with a drug/shock sequence. Do
CPR for 5 cycles (2 minutes) after a drug isadministered, then shockStill in VF: amiodirone 300 mg IV. May givean additional 150 mg if VF persistsMinimize interruptions in CPR for pulsechecks
-
8/10/2019 CA Management Ms 2006
11/53
Anti-Arrhythmics for PVT/VF After amiodirone: Lidocaine 1-1.5 mg/kg IV, may repeat in 3-5min (max 3 mg/kg)
Magnesium sulfate : 1-2 gm IV for suspectedhypomagnesemia or torsades
Procaineamide: 30 mg/min or 100 mg q5min (max 17mg/kg)Consider bicarbonate: 1mg/kg for pre-existingacidosis, drug OD, prolonged code
-
8/10/2019 CA Management Ms 2006
12/53
Endotracheal Drug Adm
VALEN: Vasopressin, atropine, lidocaine,epinephrine, naloxone
IV administration is preferable: indicatedonly when iv access cannot be obtainedDose is 2-5X the iv dose. Dilute in sterilewater
-
8/10/2019 CA Management Ms 2006
13/53
Central vs Peripheral Line
Peripheral iv is preferred because of lessinterruption of CPR
Peripherally administered drugs should befollowed by fluid bolus and arm elevationto facilitate delivery to central circulation
-
8/10/2019 CA Management Ms 2006
14/53
80 yo comes into ER with weakness.On exam he is pale and diaphoretic, butalert and oriented and complaining ofweakness. PMH: CABG, diabetesInitial EKG:
-
8/10/2019 CA Management Ms 2006
15/53
-
8/10/2019 CA Management Ms 2006
16/53
Acute anterior MIInitial evaluation
-
8/10/2019 CA Management Ms 2006
17/53
Evaluate ABCIf adequate start O2, monitor (EKG andpulse ox), IV (OMI)iv site-antecubital
Asa, heparin, pain control cardiologyconsult
-
8/10/2019 CA Management Ms 2006
18/53
His rhythm changes
-
8/10/2019 CA Management Ms 2006
19/53
-
8/10/2019 CA Management Ms 2006
20/53
What do you want to know?
-
8/10/2019 CA Management Ms 2006
21/53
Stable or unstable-presence of serioussigns and symptoms?
In this case starts out with BP114/70, iestable
-
8/10/2019 CA Management Ms 2006
22/53
Treat with amiodarone 150mg iv over 10minutes and then infusion of 1mg/min
Patient remains in VT-develops MSchanges and pulse weakensStable or unstable?Treatment
-
8/10/2019 CA Management Ms 2006
23/53
VT with pulse, unstable-cardiovertThis means a synchronized shock-youpress the synch button on the defibConsider sedationStart with 100jPatient changes as machine is charging-now pulseless and apneic
-
8/10/2019 CA Management Ms 2006
24/53
-
8/10/2019 CA Management Ms 2006
25/53
Shock 360j (or 200 biphasic) if the syncbutton is still pressed it wont work -turn off
Do CPR for 2 minutes before checkingrhythmVentilate with BVM and 100% O2, intubateStart iv, give epi or vasopressin
-
8/10/2019 CA Management Ms 2006
26/53
Intubation
Secures the airway Allows administration of 100% oxygen and
correction of respiratory acidosis Allows administration of some medications(VALEN-3X iv dose)
What if you cant intubate??
-
8/10/2019 CA Management Ms 2006
27/53
Laryngeal Mask Airway
-
8/10/2019 CA Management Ms 2006
28/53
LMA
The LMA is insertedby slipping the mask
along the palate intothe hypopharynx withsubsequent inflationof the mask rim
-
8/10/2019 CA Management Ms 2006
29/53
Epi-1 mg q3-5 min or vasopressin 40 unitsShock-still VF
Amiodarone 300mg-shock, then 150 mgthen infusion (max 2.2 grams per 24hours)Lidocaine 1-1.5 mg/kg. Repeat x1 max3mg/kg.
-
8/10/2019 CA Management Ms 2006
30/53
How do you check that the ETT is properlyplaced?
How do you know CPR is adequate
-
8/10/2019 CA Management Ms 2006
31/53
ETT placement
Listen over both lateral lung fields and thestomach
Use end tidal CO2 (but no CO2 if CPR isnot adequate)
-
8/10/2019 CA Management Ms 2006
32/53
Adequate CPR
Palpable carotid or femoral pulsePulse oximeter or A-lineCO2 production
-
8/10/2019 CA Management Ms 2006
33/53
Vasopressin in CA
Half life is 10-20 minutes, so considerwaiting at least 10 minutes to give
epinephrineComparing survival in out of hospitalarrest, no advantage of vasopressin over
epinephrine (in one study, it looked betterfor asystole)
-
8/10/2019 CA Management Ms 2006
34/53
What if they come back with a pulse butinadequate BP?
-
8/10/2019 CA Management Ms 2006
35/53
Low BP
Fluid bolusDopamine-5 micrograms/kg/min titrate (put200 mcg in 250cc and start at 30drops/min)
-
8/10/2019 CA Management Ms 2006
36/53
When to Stop ?
CV unresponsivenessYou get more info about situation andcode status
-
8/10/2019 CA Management Ms 2006
37/53
Asystole/PEA
Confirm asystole in more than one lead (uselead select to move between limb leads)
Transcutaneous pacing is ineffective for asystoleand is no longer recommendedEpinephrine: 1mg IV q3-5 min (or vasopressin*)
Atropine: 1mg IV q 3-5 min (up to 3 doses)
-
8/10/2019 CA Management Ms 2006
38/53
Consider Causes: 6Hs
HypovolemiaHypoxiaHyper, hypokalemiaHydrogen ions (acidosis)HypothermiaHypoglycemia
-
8/10/2019 CA Management Ms 2006
39/53
5Ts
ToxinsTamponade, cardiacTension pneumothoraxThrombosis (pulmonary, coronary)Trauma
-
8/10/2019 CA Management Ms 2006
40/53
PEA
Thinking of and correcting one of thereversible causes of PEA early (eg chest
tube placement for pneumothorax) can belifesaving
-
8/10/2019 CA Management Ms 2006
41/53
Improving Survival After Cardiac
Arrest After restoration of spontaneouscirculation, poor neurologic outcome is
one of major causes of death2 studies have now demonstratedimproved neurologic outcome post arrest
with the use of mild hypothermia
-
8/10/2019 CA Management Ms 2006
42/53
Mild Hypothermia after VF
Arrest136 patients comatose after VF arrest (thearrest was witnessed) were randomized to
mild hypothermia, target 32-34 Cmeasured with a bladder probe. Patientswere sedated with fentanyl and midazolam
and paralyzed with pancuronium andtemperature was maintained for 32 hours
-
8/10/2019 CA Management Ms 2006
43/53
SURVIVAL AFTER CA
-
8/10/2019 CA Management Ms 2006
44/53
-
8/10/2019 CA Management Ms 2006
45/53
ACLS: Managementof Tachycardias andBradycardias
-
8/10/2019 CA Management Ms 2006
46/53
Bradycardia and Tachycardia
AlgorithmsThe main important point is the distinction betweenstable vs unstable with serious signs and sxincluding:
HypotensionShockPulmonary edema
Loss of consciousness, confusion agitationMI , angina
-
8/10/2019 CA Management Ms 2006
47/53
Tachycardia with a Pulse
Main distinction is wide vs narrow complextachycardia. Also consider LV function.
Assume wide complex tachycardia is VTand treat with amiodarone, lidocaine orprocaineamide if stable or synchronized
cardioversion if unstableSynchronized cardioversion: sedate first,start with 100j
-
8/10/2019 CA Management Ms 2006
48/53
Wide Complex Tachycardia
Always assume it is VTThe drugs of choice for stable VT or widecomplex tachycardia of unknown origin areamiodarone and procaineamide
Adenosine and verapamil are
contraindicated for the treatment of widecomplex tachycardia
-
8/10/2019 CA Management Ms 2006
49/53
Narrow Complex TachycardiaIdentify the rhythm (carotid massage,adenosine), consider cause, duration,LV function
Tachycardia may be secondary to fever,dehydration, hypoxemia-treat theunderlying cause rather than the rhythm
No cardioversion for: sinus tachycardia,MAT, junctional tachycardia Avoid using > one drug
-
8/10/2019 CA Management Ms 2006
50/53
Atrial Flutter-Fibrillation >48h
Agents that control rate rather thanconvert the rhythm are preferred, unless
the patient is adequately anticoagulatedNormal LV function: diltiazem or betablockers (I)
Abnormal LV function(EF
-
8/10/2019 CA Management Ms 2006
51/53
Atrial Fibrillation
-
8/10/2019 CA Management Ms 2006
52/53
-
8/10/2019 CA Management Ms 2006
53/53
Avoid Panic on the First Day of
InternshipLearn the basics of ACLS including drugdoses